THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Robert Cichewicz to Antimalarials

This is a "connection" page, showing publications Robert Cichewicz has written about Antimalarials.
Connection Strength

2.009
  1. Leveraging Peptaibol Biosynthetic Promiscuity for Next-Generation Antiplasmodial Therapeutics. J Nat Prod. 2021 02 26; 84(2):503-517.
    View in: PubMed
    Score: 0.723
  2. Identification of Compounds with Efficacy against Malaria Parasites from Common North American Plants. J Nat Prod. 2016 Mar 25; 79(3):490-8.
    View in: PubMed
    Score: 0.506
  3. Fungal-derived methyldeoxaphomins target Plasmodium falciparum segregation through the inhibition of PfActin1. Proc Natl Acad Sci U S A. 2025 Feb 25; 122(8):e2418871122.
    View in: PubMed
    Score: 0.239
  4. Understanding the Antiplasmodial Action of Resistance-Refractory Xanthoquinodin A1. ACS Infect Dis. 2024 Jun 14; 10(6):2276-2287.
    View in: PubMed
    Score: 0.227
  5. Cyclic Tetrapeptide HDAC Inhibitors with Improved Plasmodium falciparum Selectivity and Killing Profile. ACS Infect Dis. 2021 10 08; 7(10):2889-2903.
    View in: PubMed
    Score: 0.188
  6. Targeting mosquito FREP1 with a fungal metabolite blocks malaria transmission. Sci Rep. 2015 Oct 06; 5:14694.
    View in: PubMed
    Score: 0.125
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES